Document is current
Any future updates will be listed below
-
Authors
Wu, Qianyun
Wu, Yanfei
Zhang, You
Guan, Yihui
Huang, Gang
Xie, Fang
Liu, Jianjun
Zhai, Wei
Wei, Weijun https://orcid.org/0000-0003-3190-2480
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (2020YFA0909000)
National Natural Science Foundation of China (82372014)
Shen Kang-United Imaging Joint Research and Development Plan (SKLY2022CRT301)
- License Information
-
More Information
Article History
Received: 23 December 2023
Accepted: 5 March 2024
First Online: 14 March 2024
Declarations
:
: All animal imaging studies were approved by the Institutional Committee for the Care and Use of Animals (Renji Hospital, Shanghai Jiao Tong University School of Medicine). The clinical study was approved by the Institutional Ethical Reviewing Board of Huashan Hospital and registered as a prospective clinical trial (ClinicalTrials.gov ID NCT06148220).
: Written informed consents were obtained from all the included patients.
: All the participants agreed to the publication of the imaging data.
: W. Wei is a consultant of Alpha Nuclide (Ningbo) Medical Technology Co., Ltd. W. Wei, Q. Wu, and J. Liu are co-inventors of three pending patents describing the disclosed imaging technologies.
